Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. |
| |
Authors: | T C Wu F G Guarnieri K F Staveley-O'Carroll R P Viscidi H I Levitsky L Hedrick K R Cho J T August D M Pardoll |
| |
Affiliation: | Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA. |
| |
Abstract: | The presentation of antigenic peptides by major histocompatibility complex (MHC) class II molecules to CD4+ T cells is critical to the function of the immune system. In this study, we have utilized the sorting signal of the lysosomal-associated membrane protein LAMP-1 to target a model antigen, human papillomavirus 16 E7 (HPV-16 E7), into the endosomal and lysosomal compartments. The LAMP-1 sorting signal reroutes the antigen into the MHC class II processing pathway, resulting in enhanced presentation to CD4+ cells in vitro. In vivo immunization experiments in mice demonstrated that vaccinia containing the chimeric E7/LAMP-1 gene generated greater E7-specific lymphoproliferative activity, antibody titers, and cytotoxic T-lymphocyte activities than vaccinia containing the wild-type HPV-16 E7 gene. These results suggest that specific targeting of an antigen to the endosomal and lysosomal compartments enhances MHC class II presentation and vaccine potency. |
| |
Keywords: | |
|
|